Unveiling prognosis in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax through novel risk stratification

Several genetic risk classification systems based on response to older acute myeloid leukemia patients treated with less-intensive regimens, especially venetoclax (VEN) + hypomethylating agent (HMA), are proposed recently. VEN+HMA improved the outcome of cytogenetic adverse-risk AML, AML with some o...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jiajia Sun, Zhiping Guo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2025-01-01
coleção:	Leukemia Research Reports
Assuntos:	Acute myeloid leukemia Genetic risk classification Venetoclax Hypomethylating agent
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2213048925000524
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!